Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
about
Discovery of Anticancer Agents of Diverse Natural OriginBiomimetic kinetic resolution: highly enantio- and diastereoselective transfer hydrogenation of aglain ketones to access flavagline natural products.Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel ActivitySilvestrol induces early autophagy and apoptosis in human melanoma cellsCyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.Chinese herb derived-Rocaglamide A is a potent inhibitor of pancreatic cancer cells.Inhibition of nasopharyngeal carcinoma cell proliferation and synergism of cisplatin with silvestrol and episilvestrol isolated from Aglaia stellatopilosa.Cytotoxic Rocaglate Derivatives from Leaves of Aglaia perviridis.CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.Cytotoxicity and Synergistic Effect of the Constituents from Roots of Aglaia odorata (Meliaceae).Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.Synthesis of Aza-Rocaglates via ESIPT-Mediated (3+2) PhotocycloadditionOverexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis.Total Syntheses of the Isomeric Aglain Natural Products Foveoglin A and Perviridisin B: Selective Excited-State Intramolecular Proton-Transfer Photocycloaddition.Rocaglates as dual-targeting agents for experimental cerebral malaria.Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol.
P2860
Q28068341-D54A498D-717C-42E6-AE53-5692DDD4ECC3Q35005931-63295659-6942-46EA-B35C-06536D7445C5Q35182091-A21E186F-53B8-4C01-AC50-43193DE2237BQ35893093-7824EF02-5F81-4F1F-A169-53B8D77AB8A7Q35956113-1B29D2EC-B178-4E94-B857-36DED116E1F5Q36011872-169D789F-50B3-409E-9874-C91900F9CAB4Q36047831-55717345-8E30-4204-A8C3-595E56CDF677Q36512335-EE0625CB-E4CC-4BEB-972E-8FB0D446DB6AQ37649874-9F9A577A-9944-43BC-97C1-A66CA68C4B44Q38903242-0D9C52D7-2608-4512-AB58-8BE0FFCB3870Q41139111-2A9C881F-90F3-4D42-A563-C63902F0E426Q41161750-BB0A35F3-FBC9-4CC5-A112-C5E2AB726883Q47144604-BFE378C9-7427-4BF7-A8D4-E5AB16D41414Q47555171-5B4B9D69-A744-47AE-88F5-9B3840EA572FQ48285564-5241E376-A1A9-435D-B7E9-FAA1F26CAFD2Q49790353-72D08C32-184D-4947-94AB-273E6145C4C5Q50238755-F623E2C4-780F-4E6D-9D85-BF548732C1F9Q55084415-BFA6BBB6-7AB1-427E-B0DA-A8259E67A2C0
P2860
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@ast
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@en
type
label
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@ast
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@en
prefLabel
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@ast
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@en
P2093
P2860
P356
P1476
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
@en
P2093
David M Lucas
James R Fuchs
John L Woodard
P2860
P304
P356
10.1039/C4NP00006D
P50
P577
2014-05-02T00:00:00Z